Pathogenic mechanisms of antiphospholipid syndrome: a new autoimmune disease
- 31 December 2004
- journal article
- review article
- Published by Elsevier in Drug Discovery Today: Disease Mechanisms
- Vol. 1 (3) , 309-314
- https://doi.org/10.1016/j.ddmec.2004.11.006
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Endothelial cell activation by antiphospholipid antibodiesClinical Immunology, 2004
- Fluvastatin inhibits up‐regulation of tissue factor expression by antiphospholipid antibodies on endothelial cellsJournal of Thrombosis and Haemostasis, 2004
- Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2003
- Dimers of β2-Glycoprotein I Increase Platelet Deposition to Collagen via Interaction with Phospholipids and the Apolipoprotein E Receptor 2′Journal of Biological Chemistry, 2003
- Specificities, properties, and clinical significance of antiprothrombin antibodiesArthritis & Rheumatism, 2003
- Effects of β2‐glycoprotein I and monoclonal anticardiolipin antibodies in platelet interaction with subendothelium under flow conditionsArthritis & Rheumatism, 2002
- Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal LossThe Journal of Experimental Medicine, 2002
- The role of tissue factor in the antiphospholipid syndromeArthritis & Rheumatism, 2001
- Experimental Thrombosis and Antiphospholipid Antibodies: New InsightsJournal of Autoimmunity, 2000
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999